Skip to content

Memory Support System Feasibility Study

Mild Cognitive Impairment

The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    50 and up

Participation Criteria

Inclusion Criteria:

* diagnosis of single or multi-domain MCI
* Clinical Dementia Rating global (CDR) score of ≤ 0.5
* Montreal Cognitive Assessment score of ≥18
* available contact with a care partner ≥ 2 times weekly
* absence or stable intake of nootropic(s) for ≥ 3 months

Exclusion Criteria:

* visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training
* concurrent participation in another related clinical trial

Study Location

Bruyere Research Institute
Bruyere Research Institute
Ottawa, Ontario
Canada

Contact Study Team

Primary Contact

Nicholas Kassabri

[email protected]
613-562-6262
Backup Contact

Neil Thomas, MD

[email protected]
613-562-6322
Study Sponsored By
Bruyere Research Institute
Participants Required
More Information
Study ID: NCT05999929